IOST vs Solayer — how do they compare? IOST trades at Rp12.41 (market cap Rp421,5M, Rp95,58M 24h volume), while Solayer trades at Rp1,197 (market cap Rp553,28M, Rp192,16M 24h volume). The key difference: Solayer is the larger of the two by market cap, and IOST's supply is capped (34,2B / 90B IOST (38%)) while Solayer's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold IOST for 78 Days and Solayer for 33 Days on average.
| IOST | LAYER | |
|---|---|---|
Market Cap | Rp421,5M | Rp553,28M |
Volume (24h) | Rp95,58M | Rp192,16M |
Circulating Supply | 34,2B / 90B IOST (38%) | 466,1M LAYER |
Typical Hold Time | 78 Days | 33 Days |
Signals from Pluang's Aura AI — not financial advice
IOST is trading at Rp12.37 with a bearish technical signal, showing strong selling pressure in moving averages and neutral oscillators. The asset has a market cap of Rp421.5M with 38% of its max supply in circulation. No major protocol updates or ecosystem news are currently driving momentum, while on-chain activity remains subdued.
The outlook is cautious due to weak technicals and limited fundamental catalysts. Key opportunities include potential oversold bounces near support, but risks of low liquidity and continued bearish momentum prevail. Investors should monitor for any network upgrades or exchange developments that could renew interest.
No Aura AI signal available yet.
What Pluang investors did over the last 30 days
IOST describes itself as an “ultra-fast,” fully fledged and decentralized blockchain network and ecosystem with its own nodes, wallets and based on the “next-generation” consensus protocol dubbed “proof-of-believability.”
Read more on IOST →Solayer is the first blockchain to use specialized hardware chips to reach over 1 million transactions per second and ultra-fast network speeds. Its InfiniSVM architecture uses advanced tech like SDN, RDMA, and InfiniBand to boost performance and lower latency. This allows for near-instant blockchain applications at massive scale.
Read more on LAYER →